Dimitry Tran was born in Vietnam and emigrated to Sydney at 22. He gave up medicine because of the cost for international students, and studied accounting and finance, finishing top of his class.
He paid for the medical degree of his brother Aengus Tran at UNSW. Aengus later built an AI tool to help pick IVF embryos as a student, which led the brothers to found Harrison.ai in Sydney in 2018.
Dimitry's part is the business side and the Americas. The company sold radiology and pathology tools through partnerships with I-MED (annalise.ai, 2021) and Sonic Healthcare (franklin.ai, 2022).
Harrison.ai raised a A$129 million Series B in November 2021 and a $112 million Series C in February 2025. In 2025 it held 12 FDA clearances and clearance in 40 countries.